ASX Rides Wall Street Tech Surge, Uranium Stocks Rebound

ASX Surges on Tech Rebound, Energy Gains as Insurers Face AI Headwinds

The Australian share market, as tracked by the ASX 200, experienced a significant upswing, climbing 0.4% by midday on Tuesday, building on the previous day’s robust 1.85% rebound. This positive momentum was largely fuelled by a strong performance on Wall Street overnight, where technology stocks led the charge, signaling a renewed investor confidence in the sector.

Across the Australian bourse, the market was awash in green, with most sectors participating in the rally. However, the financial sector, particularly insurers, and utilities lagged behind, experiencing declines.

Tech and Energy Shine as AI Enthusiasm Ignites

Technology stocks were the standout performers, with investors flocking to companies perceived to have exposure to artificial intelligence (AI), cloud computing, and emerging “next-gen” technologies. This surge reflects a broader market trend where AI-related ventures are capturing significant investor attention.

Energy stocks also found favour, with crude oil prices showing resilience. This uptick followed advisories from the United States urging vessels to avoid Iranian waters near the critical Strait of Hormuz, hinting at potential geopolitical supply concerns.

Uranium stocks, which had faced a brief period of uncertainty, bounced back strongly. Investors had previously expressed concerns about the long-term viability of nuclear power in the age of AI, but this sentiment appears to have subsided. Paladin Energy (ASX:PDN) saw a 5% increase, while Deep Yellow (ASX:DYL) jumped 7% in morning trade.

Insurers Under Pressure Amidst AI Disruption Fears

In contrast to the broader market optimism, insurance stocks faced selling pressure. The emergence of new AI-powered tools, such as Insurify’s latest offering, is raising concerns about potential disruption within the industry. Insurify’s application leverages ChatGPT to facilitate car insurance comparisons, analysing factors like vehicle details, credit history, and driving records to offer competitive rates. This development has led investors to re-evaluate the competitive landscape for traditional insurers.

Corporate Wins Boost Major Players

On the larger end of the market, Macquarie Group (ASX:MQG) demonstrated its financial prowess, with its shares rising as much as 4%. The financial services giant reported improved profits across all four of its business divisions for the December quarter and upgraded its guidance for its key commodities and global markets unit. This performance reinforces its reputation as a strong performer in the financial sector.

Treasury Wine Estates (ASX:TWE) also experienced a significant boost, jumping approximately 6%. This surge followed the resolution of a protracted dispute with its former US distributor, RNDC, bringing an end to a period of uncertainty.

Biotechnology firm CSL (ASX:CSL) announced an early-stage development collaboration with Swiss biotech Memo Therapeutics, a deal potentially worth up to US$328 million plus royalties. CSL’s shares reacted positively, trading up 1.5%.

Analysts Optimistic on Radiology Software Amidst AI

Despite broader market anxieties surrounding AI’s impact, some analysts remain bullish on specific tech sectors. Morgans, for instance, has upgraded Pro Medicus (ASX:PME) to a ‘buy’ rating, with a valuation of $290. The firm believes that AI will, in fact, drive demand for radiology software rather than diminish it, arguing that the underlying infrastructure provided by companies like Pro Medicus remains essential for AI integration. Pro Medicus shares were up 2%.

Defence Manufacturer Faces Allegations, Rejects Claims

In a notable development, defence manufacturer Electro Optic Systems (ASX:EOS) has responded forcefully to allegations made by US short seller Grizzly Research. Grizzly had previously released a critical report questioning the validity of several contracts announced by EOS, labelling them “intentionally misleading” and “utterly unrealistic,” which had led to a 16% drop in the company’s stock before a trading halt.

EOS has vehemently rejected these conclusions, calling them “misleading, manipulatory and pejorative.” The company has indicated that its legal teams in Australia and Germany are considering legal recourse. EOS shares were trading down 2%.

ASX Leaders and Laggards: A Snapshot

Today’s Top Performing Stocks (Including Small Caps):

• EM3 (Emc Gold Corp): Saw a substantial 89% jump, prompting an ASX speeding ticket inquiry regarding unusual trading activity. The company stated it was unaware of any undisclosed information and confirmed compliance with continuous disclosure rules.
• CCO (The Calmer Co Int): Rose 25%.
• PEB (Pacific Edge): Gained 24%.
• H2G (Greenhy2 Limited): Up 20%. The company has secured commitments to raise approximately $941,000 to fund the rollout of its sodium-ion batteries, hybrid inverters, and large commercial lithium-ion storage solutions.
• IPD (Impedimed Limited): Increased by 20%.
• GES (Genesis Resources): Added 20%.
• TAT (Tartana Minerals Ltd): Gained 20%. Tartana Minerals has secured $4.5 million to fund a significant drilling program in 2026, with a focus on its Nightflower silver-lead-zinc-antimony project in Queensland. The company will also utilise copper sulphate cash flow and director investments to support the program.
• AKO (Akora Resources): Rose 18%.
• AKG (Academies Aus Grp): Up 18%.
• MGA (Metalsgrovemining): Increased 17%.

Today’s Worst Performing Stocks (Including Small Caps):

• BSN (Basin Energy): Fell 26%.
• CT1 (Constellation Tech): Down 25%.
• AEL (Amplitude Energy): Dropped 21%.
• NES (Nelson Resources.): Declined 20%.
• RDN (Raiden Resources Ltd): Down 20%.
• RLG (Roolife Group Ltd): Fell 20%.
• GEM (G8 Education Limited): Plummeted 17% after announcing a significant non-cash goodwill impairment of $350 million. The company also scrapped its final dividend and paused its buyback program. While management reassured investors that the writedown would not impact FY25 EBIT guidance or breach lender covenants, the market reacted negatively to the accounting adjustment.
• ATH (Alterity Therap Ltd): Down 17%.
• ENL (Enlitic Inc.): Fell 17%.
• FHS (Freehill Mining Ltd.): Declined 14%.

Other Notable Market Movements and Announcements

• Stellar Resources (ASX:SRZ) has expanded its Tasmanian tin exploration activities with the acquisition of the Granite Tor project.
• Cannindah Resources (ASX:CAE) is focused on updating the resource at its Mt Cannindah project, with a particular interest in a potentially high-grade “Gap” within the existing resource.
• Anson Resources (ASX:ASN) has successfully produced high-purity lithium carbonate, suitable for electric vehicle batteries, from its Green River brine project in Utah.
• QMines (ASX:QML) has initiated a definitive feasibility study to economically define its Mt Chalmers copper-gold project.
• Carnavale Resources (ASX:CAV) is on track to have its Kookynie gold project shovel-ready by Q3 2026, following the award of a mining lease.
• FIN Resources (ASX:FIN) has secured $3.75 million through a placement, fully funding its maiden drilling program at the high-grade Cabin Lake gold project in Canada.
• Island Pharmaceuticals (ASX:ILA) has raised $9 million to advance its antiviral drug candidate, Galidesivir, through a US FDA Animal Rule pathway for Marburg virus.

Capital Raising and Investment News

• Brightstar Resources (ASX:BTR) has launched a share purchase plan aiming to raise up to $5 million. The funds will be allocated to the construction of the Goldfields Hub project, including a processing plant, pre-strip mining costs, and exploration at the Sandstone Gold Hub, as the company moves towards a final investment decision.

It is important to note that this article does not constitute financial product advice. Investors are encouraged to seek independent professional advice before making any investment decisions.